Evaluating a new minimally invasive surgery for glaucoma
Official title: Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery
Run by Hôpital Privé de la Baie · NCT06213805 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new, less invasive surgery for glaucoma to see if it leads to fewer complications and a quicker recovery compared to traditional surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 23 (estimated) |
| Sponsor | Hôpital Privé de la Baie Academic / other |
| Locations | 3 sites (Avranches and 2 other locations) |
| Trial ID | NCT06213805 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with specific types of glaucoma who have not achieved adequate control of their condition through medication.
✕Probably not a fit
Patients with other significant eye conditions or those who have had previous intraocular surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness and safety of a minimally invasive microsclerostomy (MIMS) procedure in patients requiring glaucoma surgery. It compares the outcomes of MIMS with traditional surgical methods, focusing on the incidence of complications and overall patient recovery. The ophthalmologist will monitor participants and gather clinical data to evaluate the benefits of this innovative approach. Patients are expected to experience fewer complications than those undergoing conventional surgery.
Why it matters
Potential benefit: If successful, this procedure could lead to safer and more effective treatment options for patients with glaucoma.
How similar studies have gone: While this approach is innovative, similar minimally invasive techniques have shown promise in other studies, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥ 18 years old who agree to participate in the study having signed informed consent * Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and open iridocorneal angle ( trabecular meshwork visible on gonioscopy, Shaffer classification grade 3-4) and healthy and mobile conjunctiva (without scars or adhesions). * Chronic angle closure glaucoma with indication for combined glaucoma and cataract surgery Exclusion Criteria: * Presence of other ophthalmological pathologies (except cataract) * History of intraocular surgery (unless cataract surgery), history of trauma, or conjunctival scarring in the quadrant planned for surgery * Visual acuity lower than "counts fingers" ", closure of the iridocorneal angle (and angle-closure glaucoma unless associated cataract surgery), neovascular glaucoma or neovascularization of the iris, pachymetry \< 490 μm or \> 620 μm. * Presence of severe systemic pathologies, pregnant or breastfeeding woman
Where it's running
-
Hôpital Privé de la Baie
Avranches, France Recruiting -
Clinique Thiers
Bordeaux, France Active not recruiting -
Fondation Rothschild
Paris, France Active not recruiting
Study contacts
- Principal investigator: Ana Miguel, MD — Hôpital Privé de la Baie
- Study coordinator: Ana Miguel, MD
- Email: myworld_ana@hotmail.com
- Phone: +33787016187
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.